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AbstrACt
Objectives To determine the short-term impact of a soft 
opt-out organ donation system on consent rates and donor 
numbers.
Design Before and after observational study using 
bespoke routinely collected data.
setting National Health Service Blood and Transplant.
Participants 205 potential organ donor cases in Wales.
Interventions The Act and implementation strategy.
Primary and secondary outcomes Consent rates at 18 
months post implementation compared with 3 previous 
years, and organ donor numbers 21 months before and 
after implementation. Changes in organ donor register 
activity post implementation for 18 months.
results The consent rate for all modes of consent was 
61.0% (125/205), showing a recovery from the dip to 
45.8% in 2014/2015. 22.4% (46/205) were deemed 
consented donors: consent rate 60.8% (28/46). Compared 
with the 3 years before the switch there was a significant 
difference in Welsh consent rates (χ2 p value=0.009). Over 
the same time period, rest of the UK consent rates also 
significantly increased from 58.6% (5256/8969) to 63.1% 
(2913/4614) (χ2 p value<0.0001), therefore the Wales 
increase cannot be attributed to the Welsh legislation 
change. Deceased donors did not increase: 101 compared 
with 104. Organ donation registration increased from 34% 
to 38% with 6% registering to opt-out.
Conclusion This is the first rigorous initial evaluation 
with bespoke data collected on all cases. The longer-term 
impact on consent rates and donor numbers is unclear. 
Concerns about a potential backlash and mass opting 
out were not realised. The move to a soft opt-out system 
has not resulted in a step change in organ donation 
behaviour, but can be seen as the first step of a longer 
journey. Policymakers should not assume that soft opt-out 
systems by themselves simply need more time to have 
a meaningful effect. Ongoing interventions to further 
enhance implementation and the public’s understanding 
of organ donation are needed to reach the 2020 target 
of 80% consent rates. Further longitudinal monitoring is 
required.
IntrODuCtIOn  
Around 6500 people are waiting for organ 
transplants in the UK.1 Organ transplanta-
tion is cost-effective and improves quality of 
life for recipients.2 Organ donation consent 
rates in the UK need to improve to keep up 
with demand for transplants.3 
Under the opt-in system in Wales, consent 
rates for deceased organ donation ranged 
between a high of 53.6% to a low of 48.5% 
between 2013 and 2015.4 In contrast consent 
rates in some other European countries are 
much higher. For example, in Spain consent 
ranges from 80% to 85% in an opt-out 
system in which all citizens are automatically 
assumed to consent to organ donation unless 
they choose to state otherwise.5
The British Medical Association, patient 
groups and newspapers6 7 have lobbied for the 
introduction of an opt-out system to replace 
the current opt-in system in the respective UK 
nations (England, Scotland, Wales, Northern 
Ireland). The UK nations have separate, and 
in the case of Scotland, Wales and Northern 
Ireland devolved, responsibilities for health. 
There are two types of ‘opt-out’ system: 
a ‘hard’ opt-out where the family are not 
consulted or a ‘soft’ opt-out where the family 
are consulted. Opinion is starkly divided as 
to the benefits of introducing either form of 
opt-out system of organ donation compared 
with reorganisation of the current opt-in 
system to increase consent rates.8 9 A compar-
ison of the opt-in and soft opt-out default 
systems can be found in table 1. Table 2 
contains key operational definitions.
Following an extensive public consulta-
tion, the Human Transplantation (Wales) 
Act 2013 introduced a soft opt-out system of 
strengths and limitations of this study
 ► Bespoke routinely collected data were analysed for 
all potential organ donor cases.
 ► A large group of patient and public representatives 
worked with researchers to co-produce the study.
 ► The study is limited to establishing short-term im-
pacts and a longitudinal study with larger numbers 
is required to determine changes over time.
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organ donation, which was fully enacted on 1 December 
2015.10 The purpose of the Act is to make it easier for 
people to donate their organs to benefit patients. The 
primary aim is to increase consent rates. In the Welsh soft 
opt-out system unless the deceased person has expressed 
a decision in life (either for or against being be an organ 
donor) it will be assumed that they have no objection to 
organ donation and their consent can be deemed. Family 
members are expected to support the donation decision 
made by their relative in life.
How the intervention is intended to work
A detailed description of the components and how the 
intervention is intended to work can be found in the study 
protocol.4 In summary, the Act, media campaign and 
implementation strategy were conceptualised as a complex 
behaviour change intervention. The Act changed the 
principles of consent to deceased organ donation from an 
opt-in to a soft opt-out system for adults 18 years or over; 
voluntarily resident for 12 months or more in Wales; who 
have not made an expressed decision regarding organ 
donation; and is competent to understand the notion of 
deemed consent. The individual must also die in Wales for 
the Act to apply. In addition to the public media campaign, 
there was an accompanying implementation strategy 
for National Health Service (NHS) and NHS Blood and 
Transplant (NHSBT) staff, which required amending 
clinical protocols and procedures and retraining large 
numbers of staff and all Specialist Nurses in Organ Dona-
tion (SNODs) covering Wales. The success of the Act 
depended on behaviour change of the public and profes-
sionals. The theory is that the neutral media campaigns 
supporting implementation will facilitate the behaviours 
in Welsh citizens outlined in box 1.
There are few examples where soft opt-out systems have 
been implemented in the context of rigorous research and 
no examples of process evaluations with family members 
who were approached about organ donation when a 
change to a soft opt-out system has been implemented. 
The aim of this study was to determine the short-term 
impact of the introduction of a soft opt-out system of organ 
donation on consent rates and organ donor numbers. 
Elsewhere we report the process evaluation findings of the 
nurse-led implementation of the soft opt-out system that 
help contextualise and explain the initial impacts.
MetHODs
We worked with NHSBT to analyse a bespoke dataset 
of routinely collected data (including the Potential 
Table 1 Comparison of the previous opt-in and new soft out-opt system in Wales
Decision type
Active Passive Geographical reach Role of family
Former opt-in system Expressed decision
Register to opt-in on the 
organ donor register
Verbally tell a relative or 
friend you want or do 
not want to be a donor
Write telling a relative or 
friend you want or do 
not want to be a donor
Nominate a 
representative to make 
the decision for you 
(nowhere to record this 
decision)
Do nothing and remain a 
non-donor
UK wide To give consent for 
organ donation
New opt-out system in 
Wales
Expressed decision
Register to opt-in on the 
organ donor register
Verbally tell a relative or 
friend you want to be a 
donor
Write telling a relative or 
friend you want or do 
not want to be a donor
Register to opt-out on 
the organ donor register
Appoint a patient 
representative on the 
organ donor register to 
make the decision for 
you




Welsh citizens have 
to die in Wales for the 
soft opt-out to apply. If 
they die in England the 
opt-in system applies
To support the donation 
decision of their relative 
made in life, but family 
members can still not 
support the donation 
decision if specific 
evidence requirements 
are met. 
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Donor Audit) on all potential organ donor cases, and 
organ donor registration activity for 18 months after the 
1 December 2015 when the soft opt-out was implemented 
in Wales, compared with up to 3 years pre implementa-
tion.4 Welsh Government shared comparative figures 
on numbers of deceased donors for 21 months before 
and after implementation.11 For the purposes of his 
study a potential organ donor was defined as a patient 
who is eligible for organ donation and whose family is 
approached for a formal organ donation discussion.
Primary and secondary outcomes
Consent rates and numbers of organ donors compared 
with previous years. Changes in organ donor register 
activity post implementation for 18 months.
Participants
All 205 potential organ donor cases in Wales were 
included.
Data collection and analysis
NHSBT bespoke routinely collected data on each case
Retrospective data on consent rates, donor numbers and 
transplant numbers are routinely collected for each finan-
cial year (12 months). We worked with NHSBT to analyse 
bespoke prospective data for 18 months post implemen-
tation on 1 December 2018. These data covered one 
full financial year and a period of months from two 
further financial years. NHSBT statisticians compiled 
summary reports of descriptive statistics for the 18-month 
post implementation period and provided reports of 
comparative retrospective data, and statistical signifi-
cance. A χ2 test was used to determine whether there was 
a statistical difference in overall consent rates between the 
Table 2 Additional key terms and operational definitions
Key term Definition
Opt-in organ donation system The default is to be a non-donor unless an individual actively registers or expresses to be an 
organ donor
Opt-out organ donation 
system
The default is presumed consent (called deemed consent in Wales) to organ donation, unless 
an individual actively opts-out
Hard opt-out organ donation 
system
The family are not consulted
Soft opt-out organ donation 
system
The family are consulted
Soft opt-out eligibility criteria 
Wales
Over 18 years, voluntarily resident in Wales, mental capacity, die in Wales
Expressed decision A person may register their decision on the organ donor register or convey it verbally or in 
writing to family members (see table 1 for options available under the different systems)
Organ donor register Under the former opt-in system individuals could only opt-in to be a donor on the register. 
With the introduction of the soft opt-out system in Wales the register was amended so 
that individuals can opt-in or opt-out of organ donation on the register, and appoint a 
representative to convey the decision for them
Presumed/deemed consent The terms are interchangeable, but in Wales the term used is deemed consent. A person* who 
has not actively expressed their organ donation decision during life is considered to have no 
objection to organ donation and their consent can be deemed 
Known donation decision The potential organ donor has made their decision known during their life-time by either 
registering it on the organ donation register or conveying it verbally or in writing to family 
members/close friends
Family consent in the soft opt-
out system
Family consent is for children under 18 years, and for potential organ donors who do not meet 
residency criteria or lack mental capacity
Organ donation decision 
overrides
Under the new soft opt-out system, family members are expected to support the organ 
donation decision of their relative made in life. To override their relative’s decision family 
members should provide witnessed written evidence or a witnessed conversation that the 
potential organ donor had changed their mind and opted for a different donation decision (the 
last known decision)
*Eligibility criteria apply. 
box 1 Intended behaviours of the citizens of Wales under 
the soft opt-out system.4
 ► Opt-in or opt-out on the organ donor register (registered decision), 
with the option of appointing a patient representative.
 ► Discuss opt-in or opt-out donation decision with families and friends 
(express decision).
 ► Do nothing and it will be assumed that the person does not object to 
organ donation (deemed consent).
 ► Families will put aside their own views on donation and respect the 
decision of the deceased person made in life.
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3 years prior to the introduction of the soft opt-out and 
deemed consent compared with the 18 months following 
the introduction of the soft opt-out and deemed consent 
(table 3).12 Rest of the UK national trends in consent 
rates were also used as a comparative context. Data 
were grouped by mode of consent (expressed and regis-
tered opt-in and opt-out; deemed, and family consent), 
and total numbers of families approached. Data on 
proceeding donors and transplants were also compared. 
In addition, Welsh Government shared their analysis of 
numbers of organ donors for 21 months pre implementa-
tion and post implementation.
Patient and public involvement
This was a co-productive study with extensive patient 
and public involvement of over 50 people and organisa-
tions in the design, analysis and interpretation of data. 
A 2-day residential meeting and an end of study event 
were convened to discuss and interpret findings. Patient 
and public involvement was most evident in the design 
and conduct of the associated process evaluation. A 
detailed report evaluating the impact of the co-produc-
tive approach and the contribution of patient and public 
representatives is published elsewhere.
results
There were 205 deceased donors in Wales of which 88.7% 
(182/205) met the criteria for a known decision [ie, they 
expressed a decision in life (either for or against being 
be an organ donor) or having their consent deemed 
(figure 1 and table 3)]. The remaining 11.2% (23/205) 
cases met the criteria for the ‘family’ mode of consent as 
the deceased person was a child, lacked mental capacity 
or did not meet residency criteria. The consent rate for 
all modes of consent was 61.0% (125/205), showing a 
recovery from the dip to 45.8% in 2014/2015. Compared 
with the consent rates in the 3 full financial years prior 
to the introduction of deemed consent in Wales there 
was a significant difference in the consent rates (χ2 p 
value=0.009). Over the same time period consent rates 
in the rest of the UK nations also significantly increased 
from 58.6% (5256/8969) to 63.1% (2913/4614) (χ2 
p value<0.0001), therefore while the observed increase 
in consent in Wales is positive, the increase cannot be 
attributed to the change in legislation in Wales.
When family consent was excluded, the consent rate for 
182/205 cases that met the criteria for a known decision 
or deemed consent was 64.2%. Just over 22% (46/182) of 
cases were deemed consented donors with a consent rate 
60.8% (28/46).
Seventy-nine per cent (162/205) had registered or 
expressed a decision, of which 62.4% (128/205) of cases 
had registered or expressed their decision to opt-in. Fifty-
seven per cent (73/128) registered to opt-in on the organ 
donor register, and 22.6% (29/128) verbally expressed to 
opt-in with their families during their lifetime. Just over 
16.5% (34/205) opted-out: 8/34 opted-out on the organ 
donor register and 26/34 expressed to their families that 
they wanted to opt-out.
Family members still overrode 15.1% (31/205) opt-in 
decisions to donate, including 16.4% (12/73) organ 
donor registered opt-in decisions; 3.4% (1/29) verbally 
expressed opt-in decisions, and 39.1% (18/46) deemed 
consents.
Of the 125/205 cases where consent to deceased dona-
tion was supported by family members, 69.6% (87/125) 
proceeded to donation. The number of deceased donors 
remained relatively static (101 compared with 104 21 
months pre implementation and post implementation).11 
The number of potential donors however fell over this 
period, so although the overall donor numbers stayed 
roughly the same, this was in the context of fewer poten-
tial donors. Finally, organ donation registration increased 
from 34% to 38%. As of June 2017, 1 181 709 people in 
Wales had opted-in and 176 011 opted-out, which is 6% of 
the population and less than the Government anticipated 
would opt-out.
DIsCussIOn
While the observed increase in consent rates in Wales 
is positive, it is too early to tell if the soft opt-out system 
will be successful in further increasing consent rates 
compared with the rest of the UK nations. It is clear from 
the analysis that the move to a soft opt-out system has not 
resulted in a step change in organ donation behaviour, 
but is the first step of a longer journey.
Although there was general support for the soft opt-out 
system, decisions made by the citizens of Wales during 
life were not consistently supported as intended by family 
members in death. The success of the soft opt-out system is 
dependent on family members supporting their relative’s 
donation decision made in life. Consent rates would have 
been higher if family members had consistently supported 
their relative’s opt-in decision, although this would apply 
to both opt-in and opt-out systems. While acknowledging 
that numbers are too small at this stage to undertake a 
more sophisticated statistical analysis, and the introduc-
tion of new modes of consent (with new potential oppor-
tunity to override) make direct comparisons difficult to 
interpret, there was an observed upward trend in family 
overrides following introduction of the soft opt-out system 
(table 3). For the 3 years prior to implementation family 
overrides ranged from 5% to 7.2%. Post implementation 
it was 15.1% over 18 months, and 29.1% in 2016/2017. 
Some of the increase can be explained by the introduc-
tion of deemed consent, which provided a new opportu-
nity to override that did not exist before. The reasons why 
family members still override their relative’s opt-in deci-
sion are numerous and complex and our process evalua-
tion published elsewhere provides a detailed explanation 
to contextualise the findings reported here. Importantly, 
process evaluation findings show that SNODs were not 
able to establish the required standard of evidence to 
override an opt-in donation decision made in life. They 
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accepted a lesser standard of evidence and donation did 
not proceed.
Assuming that the potential donor had not changed 
their decision from opt-in to opt-out, it appears that some 
family members were not able to put their own negative 
views on organ donation aside. Similarly, Shaw describes 
scenarios whereby family members objected to organ 
donation and deemed consent specifically.13 We found 
that family members have yet to accept ‘doing nothing’ 
(deemed consent) as a positive decision in support of 
organ donation. The fact that the consent rate obtained 
via deemed consent is the same as the overall consent 
rate is an important and reassuring finding. There was 
some support for Shaw’s assumption that families are 
more likely to overrule a consent that is merely presumed 
(the equivalent of deemed consent in Wales) in that 
post implementation family support for an expressed 
decision made in life (87.2% 89/102) was higher than 
for a deemed decision (60.8% 28/46).14 Nonetheless, 
post implementation, overall consent rates were brought 
down by the low rate of family consent for children, and 
potential donors who did not have mental capacity or 
meet residency criteria (34.7% 8/23).
The Act contains provision whereby a person can 
appoint a representative on the organ donor register to 
convey their donation decision when they die. Only 33 
people had appointed a representative during the time-
frame of the study (now risen to 35) and none were called 
on during the first 18 months. If people are concerned 
that their relatives may not honour their donation deci-
sion, then appointing a representative may mitigate this 
relatively common situation. There is no appetite in 
Wales to introduce a hard opt-out system that removes 
the family from the decision-making process. Family 
members may however benefit from additional educa-
tion to further clarify that it is not their decision to make 
and that their role is to support the donation decision 
made in life by their relative.  Families do however have 
the right to override their relative's donation decision in 
a soft opt-out system. The rate of family overrides needs 
monitoring in the long-term to determine if the observed 
upward trend is a cause for concern that requires further 
investigation.
At an individual potential donor level it has been 
made easier to convey a decision to donate organs. Sixty 
per cent of cases were either registered on the organ 
donor register or had discussed their donation decision 
with family member(s), and as of March 2018, 39% of the 
population are registered to opt-in to donate on the organ 
donor register. Any fears that introducing an opt-out 
system would cause a backlash by somehow changing 
the concept of the ‘gift’ of organ donation has not been 
realised. Only a relatively small number of people have 
thus far opted out (6%) on the organ donor register, and 
people are still opting in more than previously.
We performed a robust evaluation of initial impact 
based on bespoke routinely collected data on all cases. A 
more complex analysis was not performed given the small 
numbers involved in the first 18 months following intro-
duction of the soft opt-out system and deemed consent 
in Wales. Small numbers, year on year fluctuations in 
potential deceased donors and consent rates, and health 
systems issues help explain why it has been difficult histor-
ically to establish if an opt-out system is the right option 
to introduce, and why increased consent rates have not 
yet translated into increased donor numbers. In Spain, 
it took 10 years following introduction of a soft opt-out 
system and further reorganisation to achieve 80% consent 
Figure 1 Flow diagram of post implementation consent decisions.
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rates and increased donor numbers.4–6 As a trial was not 
feasible, it was not possible to determine with certainty 
if the 60.8% (28/46) of families who supported deemed 
consent under the soft opt-out system would have given 
their consent anyway under the former opt-in system. Nor 
do we know for sure why overall consent rates dropped by 
5% to 48.5% immediately prior to implementation of the 
Act. Nonetheless, since its introduction there has been 
a sustained recovery and a 12.5% improvement since 
2013/2014. One explanation is that there was a high 
profile coroner’s case in Wales in December 2014, which 
received international attention.15 Donor numbers across 
the UK fell following the news coverage (the only year on 
year fall in donor numbers in the UK in the last decade). 
One additional hypothesis is that introducing a soft 
opt-out system created harm that caused the pre imple-
mentation drop. McCartney writing in the BMJ9 suggested 
that ‘some or many of those opting out may have been 
willing to donate freely but not under uncertain legisla-
tion’. This was a view supported by patient and public 
representatives who co-produced the current study. In a 
separate analysis of media coverage,16 we found a change 
to a more positive and supportive tone after 1 December 
2015 when the soft opt-out was fully implemented that 
aligns with a general trend in improvements to consent 
rates.
Discounted over 10 years, the costs were approxi-
mately £7.5 million to set up and maintain the infrastruc-
ture required to operate a soft opt-out system of organ 
donation, including business and system changes, the 
processing of opt-out requests, public communications 
and evaluation. An increase of one donor per year with 
associated increases in organ transplantations, would 
generate sufficient benefits for a soft opt-out system to 
more than pay for itself.17 With this in mind, further 
attention needs to be given to reducing the number 
of consented donors who do not proceed to donation. 
During the 18 months post implementation around 30% 
of consented donors did not proceed. Our process evalua-
tion sheds more light on the issues that prevent donation 
proceeding, some of which are amenable to intervention 
to reduce this figure.
Our findings have important implications for other 
nations including the Netherlands, Scotland and 
England who have signalled an intention or decision 
to implement a soft opt-out system.18–21 Our process 
evaluation makes clear that there are many different 
issues that impact on whether or not a family supports 
their relative’s organ donation decision, which could 
be addressed. A longitudinal study is required to see if 
consent rates are maintained, continue to improve and 
subsequently reach the national UK target of 80% by 
2020,22 and to monitor what happens to donor numbers. 
Having accumulated more data since the conclusion of 
this study, other NHSBT studies are underway which are 
looking into this. We also need to know and understand 
the specific reasons why 6% of people have opted out on 
the organ donor register.
COnClusIOn
We found that introduction of the soft opt-out reversed 
a decline and subsequently improved consent rates for 
deceased organ donation in Wales that were similar to 
other improvements in consent rates in the rest of the 
UK nations who had not implemented a soft opt-out 
system; and had no impact on donor numbers. While 
the soft opt-out system in Wales has been most successful 
in getting potential organ donors to register or verbally 
express their decision, or do nothing and have their 
consent deemed, it was primarily family member over-
rides and health systems issues that prevented support for 
their relative’s opt-in donation decision and successful 
donation.
Given the growing worldwide interest in introducing 
opt-out systems and the unclear long-term impact on 
consent and donation rates these findings should be 
considered by policymakers who may assume that soft 
opt-out systems by themselves simply need more time to 
have a meaningful effect on donation numbers.
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